Guangdong Historical Cash Flow
| 603983 Stock | 30.98 1.49 5.05% |
Analysis of Guangdong Marubi cash flow over time is an excellent tool to project Guangdong Marubi Bio future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 19.4 M or Dividends Paid of 109.5 M as it is a great indicator of Guangdong Marubi ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Guangdong Marubi Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Guangdong Marubi Bio is a good buy for the upcoming year.
Guangdong |
About Guangdong Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Guangdong balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Guangdong's non-liquid assets can be easily converted into cash.
Guangdong Marubi Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Guangdong Marubi Bio to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Guangdong Marubi operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Guangdong Marubi Bio financial statement analysis. It represents the amount of money remaining after all of Guangdong Marubi Biotechnology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Most accounts from Guangdong Marubi's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Guangdong Marubi Bio current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Guangdong Marubi Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Guangdong Marubi's Other Cashflows From Financing Activities is projected to increase significantly based on the last few years of reporting. The current year's Dividends Paid is expected to grow to about 109.5 M, whereas Change To Inventory is forecasted to decline to (34.7 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Dividends Paid | 141.9M | 76.8M | 106.1M | 109.5M | Depreciation | 20.1M | 26.5M | 24.6M | 19.4M |
Guangdong Marubi cash flow statement Correlations
Click cells to compare fundamentals
Guangdong Marubi Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Guangdong Marubi cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (63.4M) | 42.8M | (14.0M) | (25.2M) | (33.1M) | (34.7M) | |
| Investments | (720M) | (75.7M) | (572.8M) | 70.1M | (215.2M) | (225.9M) | |
| Change In Cash | 538.1M | (444.5M) | (858.5M) | 263.5M | (22.4M) | (21.3M) | |
| Total Cashflows From Investing Activities | (56.2M) | (699.4M) | (782.1M) | (681.1M) | (613.0M) | (582.4M) | |
| Depreciation | 15.6M | 12.6M | 20.1M | 26.5M | 24.6M | 19.4M | |
| Capital Expenditures | 6.4M | 748.9M | 117.1M | 110.9M | 254.0M | 173.5M | |
| Total Cash From Operating Activities | 465.5M | 362.3M | (7.5M) | 48.4M | 338.0M | 229.3M | |
| Net Income | 514.9M | 464.4M | 247.9M | 174.2M | 259.4M | 262.0M | |
| End Period Cash Flow | 2.1B | 1.7B | 798.5M | 1.1B | 1.0B | 1.0B | |
| Other Cashflows From Investing Activities | 25.1M | 27.0M | 42.5M | 10.6M | 12.2M | 23.8M | |
| Change To Netincome | (25.1M) | (20.9M) | (40.9M) | (13.2M) | (11.8M) | (12.4M) | |
| Change To Liabilities | 87.0M | 25.5M | (80.3M) | (141.0M) | (126.9M) | (120.6M) | |
| Free Cash Flow | 459.1M | (386.6M) | (124.6M) | (62.5M) | 84.0M | 94.2M | |
| Change In Working Capital | (45.2M) | (105.9M) | (269.0M) | (138.3M) | 132.6M | 139.2M | |
| Begin Period Cash Flow | 1.6B | 2.1B | 1.7B | 798.5M | 1.1B | 1.1B | |
| Other Non Cash Items | 9.4M | 2.3M | 13.0M | 14.1M | 7.7M | 10.3M |
Currently Active Assets on Macroaxis
Other Information on Investing in Guangdong Stock
The Cash Flow Statement is a financial statement that shows how changes in Guangdong balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Guangdong's non-liquid assets can be easily converted into cash.